A randomised comparison of two faecal immunochemical tests in population-based colorectal cancer screening

Gut

Volumn 66, Issue 11, 2017, Pages 1975-1982

  Grobbee, E J ^a   Van Der Vlugt, M ^b   Van Vuuren, A J ^a   Stroobants, A K ^b   Mundt, M W ^c   Spijker, W J ^d   Bongers, E J C ^e   Kuipers, E J ^a   Lansdorp Vogelaar, I ^a   Bossuyt, P M ^f   Dekker, E ^b   Spaander, M C W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c Flevoziekenhuis Almere ^*  (Netherlands)

^d Nationwide Screening Organization for the South western Netherlands   (Netherlands)

^e Foundation of Population screening Mid West   (Netherlands)

^f UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

COLORECTAL CANCER SCREENING; COLORECTAL CARCINOMA

Indexed keywords

HEMOGLOBIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CLINICAL EVALUATION; COHORT ANALYSIS; COLORECTAL CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD TEST; PREDICTIVE VALUE; PRIORITY JOURNAL; COLONOSCOPY; COLORECTAL NEOPLASMS; COMPUTED TOMOGRAPHIC COLONOGRAPHY; EARLY CANCER DIAGNOSIS; FOLLOW UP; IMMUNOLOGICAL TECHNIQUE; MIDDLE AGED; OCCULT BLOOD; PATIENT ATTITUDE; PILOT STUDY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; STATISTICS AND NUMERICAL DATA;

AGED; COLONOGRAPHY, COMPUTED TOMOGRAPHIC; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOLOGIC TECHNIQUES; MALE; MIDDLE AGED; OCCULT BLOOD; PATIENT ACCEPTANCE OF HEALTH CARE; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS;

EID: 84981495362     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2016-311819     Document Type: Article

References (30)

1. Center MM, Jemal A, Ward E. International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev 2009;18:1688-94.
2. Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 2010;116:544-73.
3. Kuipers EJ, Grady WM, Lieberman D, et al. Colorectal cancer. Nat Rev Dis Primers 2015;1:15065.
4. Shaukat A, Mongin SJ, Geisser MS, et al. Long-Term mortality after screening for colorectal cancer. N Engl J Med 2013;369:1106-14.
5. Hol L, de Jonge V, van Leerdam ME, et al. Screening for colorectal cancer: comparison of perceived test burden of guaiac-based faecal occult blood test, faecal immunochemical test and flexible sigmoidoscopy. Eur J Cancer 2010;46:2059-66.
6. Brenner H, Tao S. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-To-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy. Eur J Cancer 2013;49:3049-54.
7. van Rossum LG, van Rijn AF, Laheij RJ, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008;135:82-90.
8. Rabeneck L, Rumble RB, Thompson F, et al. Fecal immunochemical tests compared with guaiac fecal occult blood tests for population-based colorectal cancer screening. Can J Gastroenterol 2012;26:131-47.
9. Faivre J, Dancourt V, Denis B, et al. Comparison between a guaiac and three immunochemical faecal occult blood tests in screening for colorectal cancer. Eur J Cancer 2012;48:2969-76.
10. Hol L, van Leerdam ME, van Ballegooijen M, et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 2010;59:62-8.
11. Tinmouth J, Lansdorp-Vogelaar I, Allison JE. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know. Gut 2015;64: 1327-37.
12. Schreuders EH, Ruco A, Rabeneck L, et al. Colorectal cancer screening: A global overview of existing programmes. Gut 2015;64:1637-49.
13. Chiang TH, Chuang SL, Chen SL, et al. Difference in performance of fecal immunochemical tests with the same hemoglobin cutoff concentration in a nationwide colorectal cancer screening program. Gastroenterology 2014;147:1317-26.
14. Fraser CG, Allison JE, Halloran SP, et al. A Proposal to Standardize Reporting Units for Fecal Immunochemical Tests for Hemoglobin. J Natl Cancer Inst 2012;104:810-14.
15. Lee JK, Liles EG, Bent S, et al. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-Analysis. Ann Intern Med 2014;160:171.
16. Stegeman I, de Wijkerslooth TR, Mallant-Hent RC, et al. Implementation of population screening for colorectal cancer by repeated Fecal Immunochemical Test (FIT): Third round. BMC Gastroenterol 2012;12:73.
17. Kapidzic A, Grobbee EJ, Hol L, et al. Attendance and yield over three rounds of population-based fecal immunochemical test screening. Am J Gastroenterol 2014;109:1257-64.
18. Denters MJ, Deutekom M, Fockens P, et al. Implementation of population screening for colorectal cancer by repeated fecal occult blood test in the Netherlands. BMC Gastroenterol 2009;9:28.
19. Denters MJ, Deutekom M, Bossuyt PM, et al. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer. Gastroenterology 2012;142:497-504.
20. Stegeman I, van Doorn SC, Mundt MW, et al. Participation, yield, and interval carcinomas in three rounds of biennial FIT-based colorectal cancer screening. Cancer Epidemiol 2015;39:388-93.
21. Schlemper RJ, Riddell RH, Kato Y, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000;47:251-5.
22. Hamilton SR, Rubio CA, Vogelstein B, et al. World Health Organization classification of tumours. Tumours of the digestive system. In: Hamilton SR, Aaltonen LA, eds. Pathology and genetics of tumours of the digestive system. Lyon, France, IARC press ISBN 92 832 2410 8, 2000:103-142.
23. Edge SB, Compton CC. The American Joint Committee on Cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010;17:1471-4.
24. Zubero MB, Arana-Arri E, Pijoan JI, et al. Population-based colorectal cancer screening: comparison of two fecal occult blood test. Front Pharmacol 2014;4:175.
25. Santare D, Kojalo I, Huttunen T, et al. Improving uptake of screening for colorectal cancer: A study on invitation strategies and different test kit use. Eur J Gastroenterol Hepatol 2015;27:536-43.
26. FOB-Gold, Hb Fecal Immunochemical Test-Sentinel Diagnostics. Sentinel Diagnostics. http://www.sentinel.it/en/fob-gold-line/fobgold.aspx
27. Väänänen P, Tenhunen R. Rapid immunochemical detection of fecal occult blood by use of a latex-Agglutination test. Clin Chem 1988;34:1763-6.
28. Carroll M, Piggot C, Pearson S, et al. Evaluation of quantitative faecal immunochemical tests for haemoglobin. NHS Bowel Cancer Screening Southern Programme Hub, 2014.
29. Guittet L, Guillaume E, Levillain R, et al. Analytical comparison of three quantitative immunochemical fecal occult blood tests for colorectal cancer screening. Cancer Epidem Biomar 2011;20:1492-501.
30. Rubeca T, Rapi S, Confortini M, et al. Evaluation of diagnostic accuracy of screening by fecal occult blood testing (FOBT). Comparison of FOB Gold and OC Sensor assays in a consecutive prospective screening series. Int J Biol Markers 2006;21:157-61.